The findings reported by Elkind et al. on the 467 ischemic stroke patients included in the population-based Northern Manhattan Stroke Study indicated that stroke patients with higher Lp-PLA2 activity had an increased risk of recurrence after the first ischemic stroke [51]. This evidence concerns the gene PLA2G7 and Stroke.